American Oriental Bioengineering, Inc.
AOBI · OTC
12/31/2012 | 12/31/2011 | 12/31/2010 | 12/31/2009 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -31.8% | -30.5% | 3.3% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 30.6% | 46.9% | 51.6% | 56.3% |
| EBITDA | -$0 | -$0 | $0 | $0 |
| % Margin | -27.3% | -22.9% | 13.7% | 24.5% |
| Net Income | -$0 | -$0 | $0 | $0 |
| % Margin | -41.2% | -32.2% | 4.6% | 14% |
| EPS Diluted | -781.24 | -901.8 | 185.37 | 1,062.12 |
| % Growth | 13.4% | -586.5% | -82.5% | – |
| Operating Cash Flow | -$0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | $0 | $0 |